Skip to main content

Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.

Barták BK, Kalmár A, Galamb O, Wichmann B, Nagy ZB, Tulassay Z, Dank M, Igaz P, Molnár B

Publication: Pathol Oncol Res (2018)PMID: 29374860View on PubMed

Purpose

This paper investigated the effects of diagnosis, tube type and cell-free DNA (cfDNA) extraction kit on the cfDNA yield and methylation rate.

Conclusion

Methylation rates were dependent on extraction kit, diagnosis and promoter, but were generally higher in patients with adenoma or CRC than healthy controls. cfDNA yields were comparable from plasma collected in K3EDTA tubes and processed within 4 h and that collected in Streck BCT tubes and processed 48 h later. In adenoma patients, methylation levels were comparable between tube types, but in colorectal carcinoma (CRC) patients, higher methylation levels were observed in specimens collected in K3EDTA than Streck BCT tubes. 

Studies (4)

Purpose

This study compared methylation rates of cfDNA extracted from plasma using the High Pure Viral Nucleic Acid Large Volume Kit and the Epi proColon 2.0 kits. The effects of diagnosis on methylation was also investigated.  Blood was collected from 10 healthy, 10 adenoma and 10 CRC patients in K3EDTA tubes. Within 4 h, plasma was obtained by double centrifugation at 1350 x g for 12 min) and then stored at -20˚C until DNA extraction. cfDNA was extracted from the EDTA plasma of using the High Pure Viral Nucleic Acid Large Volume Kit and the Epi proColon 2.0 kits. Bisulfite conversion was performed using the EZ DNA Methylation Direct Kit and converted DNA was used immediately or stored at -80˚C. Methylation of SFRP1, SFRP2, SDC2 and PRIMA1 promoters was quantified using the MethylLight PCR and methylated was defined as greater than 0.1% methylation.

Summary of Findings

As expected, more than 0.1% methylation occurred at a lower rate in healthy controls (0-30%) than in patients with adenoma (10-100%) or CRC (30-90%) and while consistently higher in adenoma or CRC than in healthy controls values were dependent on extraction method and promoter. Extraction and bisulfite conversion using the Epi proColon kit resulted in lower average levels of methylation than the High Pure Viral Nucleic Acid Large Volume kit for SFRP1 (2.4% versus 5.5%), SFRP2 (0.4% versus 1.4%, SDC2 (0.8% versus 4.5%) and PRIMA1 (14.6% versus 22.8%).  Methylation of SFRP1 was comparable between kits in healthy (30%, both) and CRC patients (90%, both), but was higher when extraction was with HighPure in adenoma patients (100% versus 70%). Methylation of SFRP2 and SDC2 were higher when extraction was with HighPure rather than the Epi proColon kit in healthy (10% versus 0% and 20% versus 10%, respectively), adenoma (50% versus 10% and 90% versus 30%, respectively), and CRDC patients (90% versus 30% and 80% versus 50%, respectively).

  • Biospecimens

    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticBenign
    Normal
  • Platforms

    DNABisulfite conversion assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Adenoma
    CRC
    Normal
    Analyte Extraction and PurificationAnalyte isolation method
    Epi proColon 2.0 Kit
    High Pure Viral Nucleic Acid Large Volume Kit
    Bisulfite conversion assay SpecificTargeted nucleic acid
    PRIMA1
    SDC2
    SFRP1
    SFRP2